SYNTHORX INC. - COMMON STOCK (THOR)
(Delayed Data from NSDQ)
$17.04 USD
+0.23 (1.37%)
Updated May 3, 2019 04:00 PM ET
After-Market: $16.96 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[THOR]
Reports for Purchase
Showing records 1 - 20 ( 177 total )
Industry: Medical - Biomedical and Genetics
2020 Catalyst Calendar and Top Picks Across Mid, Small, and Micro Caps
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
The Hammer Strikes; Sanofi to Acquire Synthorx for a 168% Premium
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
3Q19 Updates; Awaiting Preliminary Outcomes From the HAMMER During Mid-2020
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
EGA Platform Expands Beyond I/O and Into AI With THOR-809
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
2H19 Value Drivers Within Our Coverage Universe
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
With THOR-707 Now in the Clinic, We Are Waiting for HAMMER to Deliver
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
How Very Apt; THOR-707 Debuts With the HAMMER Study
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
More Pre-Clinical Color Ahead of Patient Dosing Expected to Commence Imminently
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
Counting Down to THOR-707 Clinical Debut During 2Q19
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
Thoughts Post AACR; THOR-707''s Not-Alpha IL-2 Profile Could Offer a Larger Therapeutic Window vs. Peers
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
Counting Down to THOR-707''s Clinical Debut
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Biomedical and Genetics
Designer Cytokines for IO and AI; Initiating With a Buy and $30 Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D